Mr Hrishi Joshi Skip To Content
Mr Hrishi Joshi

Mr Hrishi Joshi

Consultant Urological Surgeon

MS, MD, FRCS, FRCS (Urol), FEBU, PGCME

Specialises in

Prostate: Holmium Laser Enucleation of prostate (HoLEP), Urolift, Rezume, TURP.

Kidney stones: Shock wave Lithotripsy (SWL), Ureteroscopy and laser treatments.

Book an appointment with Mr Hrishi Joshi Book an consultation

Conditions and Treatments

  • Biopsy
  • Holmium Laser Enucleation of the Prostate (HoLEP)
  • Resection of prostate (TURP - transurethral removal of prostate)

Professional bio

Mr Hrishi Joshi is a Consultant Urological Surgeon and Honorary Senior Lecturer at the University Hospital of Wales since 2007. He completed his Doctor of Medicine degree in Bristol and Specialist urological training in East Anglia (Cambridge Deanery) 1999-2006. Mr Joshi has special interests in the minimally invasive management of prostate disorders and kidney stones. He has a national and international recognition for the delivery of urological services and research.

Mr Joshi mentors senior trainees as well as consultant colleagues across UK. He has received multiple national and international prizes and grants for the research and services in these field.

Mr Joshi is a lead for the management of benign prostatic diseases, stones and endourology services at the University Hospital of Wales at the current time. 

Special Clinical Interests

Treatment for enlarged prostate and PSA, Urinary tract symptoms
Kidney stones
General Urology
 

Research Interests

Mr Joshi has published over 60 papers in the peer reviewed journals and book chapters.

Some recent papers are as below:
1)Urinary Stones and Intervention Quality of Life (USIQoL): Development and Validation of a New Core Universal Patient-reported Outcome Measure for Urinary Calculi:  
Eur Urol Focus. 2021 Jan 8:S2405-4569(20)30313-8
2)Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: How consistent are we? - Results from the multi-institutional Audit of Surgical Management of BPE (AuSuM BPE) in the United Kingdom: Scott Med J 2021 May;66(2):58-65. doi: 10.1177/0036933020977295
3)Ureteric stents: Overview of current clinical applications and economic implications: Sali GM, Joshi HB.: Int J Urol. 2020 Jan;27(1):7-15. 
4)The impact of urinary stone disease and their treatment on patients’ quality of life: a qualitative study: Urolithiasis. 2020; 48(3): 227–234. 
5)Japanese linguistic validation of the ureteral stent symptom questionnaire. International Journal of Urology. 29. 10.1111/iju.14796.
 

Qualifications

MBBS and MS, B J Medical College
University of Poona, India
MD, University of Bristol
 

Year of first medical qualification: 1990

Professional Memberships

European Association of Urology 
British Association of Urological Surgeons 
BAUS Section of Endourology 
Endourological Society

Committee Membership: National and International –
Council Member for the Royal College of physicians and Surgeons Glasgow Dec 21 on
European Lithiasis Society (EULIS 2019 on) for European Association of Urology 
Co-opted member Audit and Research committee of the BAUS section of Endourology (June 2014 -2018) 
National Committee member NIHR nephor-urology portfolio group for Urology-Nephrology (group 2) – represent Wales
National lead for AuSuM BPE (Audit on Surgical management of BPE) 2017-2019
BPH Task group Wales and NIHR urology group

 

Personal Profile

Association of Clinical Informatics – Associate member (2019-20)
Member Specialist Advisory Committee in Urology (from 2022)

Current NHS/Research Position

Consultant Urological Surgeon at UHW and Honorary Senior Lecturer

Awards

The Clinical Leadership Award –first award for the senior clinicians for outstanding clinical leadership skills and competence by The Royal College of Physicians and Surgeons of Glasgow (2022)
Awarded Bevan exemplar technology award 2019
MediWales 2020 innovation award finalist with contribution to Welsh BPH Task group

Clinical Outcomes

BAUS national Audits: Outcomes for surgical treatments for stones and BPE: consistently above national average for success and complication rates.